(1) The Board of
Medical Examiners and the Board of Pharmacy shall promulgate standard protocols
consistent with the recommendation of the Joint Committee establishing the
patient care services that may be rendered under an Agreement.
Protocols deviating from the standard
protocols shall be submitted to the Joint Committee for recommendation for
approval. When evaluating whether to recommend the approval or denial of a
non-standard Protocol, the Joint Committee shall consider certain factors,
including, but not limited to:
Collaborating Physician's and Collaborating Pharmacist's education, training,
experience, and specialty;
Collaborating Physician's and Collaborating Pharmacist's disciplinary history
and any licensure restrictions;
FDA approved usages and recommendations;
(d) Whether a proposed Protocol is within the
current standard of care for treatment of the disease or condition specified in
the Protocol, including usages known as "off-label," and whether the use is
supported by evidence-based research;
(e) Whether the proposed Protocol creates an
undue risk of harm to patients; and
(f) The routine scope of practice and
services provided by the Collaborating Physician and Collaborating
consideration of the factors listed herein, the Joint Committee may recommend
approval or denial of a non-standard Protocol in whole or in part.
Ala. Admin. Code r.
Administrative Monthly Volume XXXIX, Issue No. 11, August 31,
2021, eff. 4/12/2021.
Author: Alabama Board of Medical
Code of Ala.
Act 2019-368 (Code of Ala. 1975, §